<DOC>
	<DOC>NCT01417234</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of the Spiracur SNaP® Wound Care System for the treatment of acute trauma and acute surgical excision wounds. The secondary purpose will be to compare the prospective patients to retrospectively treated acute trauma wounds to further evaluate efficacy and safety.</brief_summary>
	<brief_title>Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<criteria>Trauma wound, pressure ulcer, post operative wound, colostomy takedown site, or other acute wound deemed appropriate by study investigator(s) as the source of the wound on any part of the body including head and neck, torso, and extremities Wound &lt; 16 cm in greatest diameter Subject ≥ 18 years of age Exudate &lt; 25 ml/ day (estimate) Female subjects of childbearing potential must be willing to take a urine pregnancy test prior to starting study Subject is willing and able to sign informed consent Wound &gt; 45 days old Woundrelated cellulitis Wound located in an area not amenable to forming an airtight seal Subject has untreated osteomyelitis Subject is allergic to wound care products Wound has exposed blood vessels not suitable for negative pressure therapy Subject is pregnant Subject is actively participating in other clinical trials that conflict with current study Subject has fistulas</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>